A citation-based method for searching scientific literature

Christopher Chen, Gurleen Kaur, Puja K Mehta, Doralisa Morrone, Lucas C Godoy, Sripal Bangalore, Mandeep S Sidhu. Cardiovasc Drugs Ther 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease.
Glaucylara R Geovanini, Luis H W Gowdak, Alexandre C Pereira, Naury de Jesus Danzi-Soares, Luciana O C Dourado, Nilson T Poppi, Luiz Antonio Machado Cesar, Luciano F Drager, Geraldo Lorenzi-Filho. Chest 2014
21
50

Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Paolo G Camici, Steffen Gloekler, Bernard I Levy, Emmanouil Skalidis, Ercole Tagliamonte, Panos Vardas, Gerd Heusch. Int J Cardiol 2016
24
50

Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
Michal Tendera, Kim Fox, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Hélène Abergel, Cezar Macarie, Jean-Claude Tardif, Panos Vardas, José Zamorano,[...]. Int J Cardiol 2014
21
50

Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
Thomas J Ford, Eric Yii, Novalia Sidik, Richard Good, Paul Rocchiccioli, Margaret McEntegart, Stuart Watkins, Hany Eteiba, Aadil Shaukat, Mitchell Lindsay,[...]. Circ Cardiovasc Interv 2019
40
50

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset,[...]. Eur Heart J 2020
50

Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Lucia Jedlickova, Lucia Merkovska, Lucia Jackova, Martin Janicko, Jan Fedacko, Bozena Novakova, Anna Chmelarova, Jaroslav Majernik, Daniel Pella. Adv Ther 2015
10
50

The many faces of myocardial ischaemia and angina.
Bernard I Levy, Gerd Heusch, Paolo G Camici. Cardiovasc Res 2019
21
50

Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.
L Simon, B Ghaleh, L Puybasset, J F Giudicelli, A Berdeaux. J Pharmacol Exp Ther 1995
139
50


Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
Ph Gabriel Steg, Roberto Ferrari, Ian Ford, Nicola Greenlaw, Jean-Claude Tardif, Michal Tendera, Hélène Abergel, Kim M Fox. PLoS One 2012
68
50

Changes in heart rate and heart rate variability before ambulatory ischemic events(1).
W J Kop, R J Verdino, J S Gottdiener, S T O'Leary, C N Bairey Merz, D S Krantz. J Am Coll Cardiol 2001
72
50

Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
Ariel Diaz, Martial G Bourassa, Marie-Claude Guertin, Jean-Claude Tardif. Eur Heart J 2005
539
50

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
Emmanuelle Vidal-Petiot, Ian Ford, Nicola Greenlaw, Roberto Ferrari, Kim M Fox, Jean-Claude Tardif, Michal Tendera, Luigi Tavazzi, Deepak L Bhatt, Philippe Gabriel Steg. Lancet 2016
241
50

The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease.
Steffen Gloekler, Tobias Traupe, Michael Stoller, Deborah Schild, Hélène Steck, Ahmed Khattab, Rolf Vogel, Christian Seiler. Heart 2014
40
50

Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
Jean-Guillaume Dillinger, Vincent Maher, Cristiana Vitale, Patrick Henry, Damien Logeart, Stephane Manzo Silberman, Guillaume Allée, Bernard I Levy. Hypertension 2015
31
50


Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.
Poghni A Peri-Okonny, Krishna K Patel, Philip G Jones, Tracie Breeding, Kensey L Gosch, John A Spertus, Suzanne V Arnold. J Am Coll Cardiol 2018
10
50

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Florian Custodis, Magnus Baumhäkel, Nils Schlimmer, Franka List, Christoph Gensch, Michael Böhm, Ulrich Laufs. Circulation 2008
198
50


Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate.
Ercole Tagliamonte, Teresa Cirillo, Fausto Rigo, Costantino Astarita, Antonino Coppola, Carlo Romano, Nicola Capuano. Adv Ther 2015
21
50

Exploring HCN channels as novel drug targets.
Otilia Postea, Martin Biel. Nat Rev Drug Discov 2011
140
50

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
50

Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
E Amosova, E Andrejev, I Zaderey, U Rudenko, C Ceconi, R Ferrari. Cardiovasc Drugs Ther 2011
50
50

β-adrenoceptor blockers valuable but higher doses not necessary.
Simon B Dimmitt, Hans G Stampfer, John B Warren. Br J Clin Pharmacol 2014
9
50

Late sodium current inhibition in human isolated cardiomyocytes by R 56865.
B Le Grand, A Coulombe, G W John. J Cardiovasc Pharmacol 1998
13
50

Innovative approaches to anti-arrhythmic drug therapy.
Stanley Nattel, Leif Carlsson. Nat Rev Drug Discov 2006
147
50

Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine.
Dmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, Tetsuya Kobayashi, Gregory T Notte, Rao Kalla, Robert H Jiang, Xiaofen Li, Thao D Perry, Belem Avila,[...]. Bioorg Med Chem Lett 2016
22
50

Optimization of Ca(v)1.2 screening with an automated planar patch clamp platform.
Bharathi Balasubramanian, John P Imredy, David Kim, Jacob Penniman, Armando Lagrutta, Joseph J Salata. J Pharmacol Toxicol Methods 2009
23
50

Benzopyran sulfonamides as KV1.5 potassium channel blockers.
John Lloyd, Karnail S Atwal, Heather J Finlay, Michael Nyman, Tram Huynh, Rao Bhandaru, Alexander Kover, Joan Schmidt, Wayne Vaccaro, Mary Lee Conder,[...]. Bioorg Med Chem Lett 2007
15
50


Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety.
Abdullah Shaito, Duong Thi Bich Thuan, Hoa Thi Phu, Thi Hieu Dung Nguyen, Hiba Hasan, Sarah Halabi, Samar Abdelhady, Gheyath K Nasrallah, Ali H Eid, Gianfranco Pintus. Front Pharmacol 2020
48
50

Electrophysiologic effects of SB-237376: a new antiarrhythmic compound with dual potassium and calcium channel blocking action.
Xiaoping Xu, Gan-Xin Yan, Ying Wu, Tengxian Liu, Peter R Kowey. J Cardiovasc Pharmacol 2003
11
50


Detailed insight on β-adrenoceptors as therapeutic targets.
Bharath Kumar Velmurugan, Rathinasamy Baskaran, Chih-Yang Huang. Biomed Pharmacother 2019
6
50

Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.
Balázs Horváth, Tamás Hézső, Dénes Kiss, Kornél Kistamás, János Magyar, Péter P Nánási, Tamás Bányász. Front Pharmacol 2020
13
50


Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels.
Zhenying Zhao, Yongqiang Yin, Hong Wu, Min Jiang, Jianshi Lou, Gang Bai, Guo'an Luo. Cell Physiol Biochem 2013
15
50



Synthesis and Ca2+ antagonistic activity of 2-[2-[(aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H- 1,4-benzothiazines.
M Fujita, S Ito, A Ota, N Kato, K Yamamoto, Y Kawashima, H Yamauchi, J Iwao. J Med Chem 1990
33
50


Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
M L Hoefle, S G Hastings, R F Meyer, R M Corey, A Holmes, C D Stratton. J Med Chem 1975
68
50

The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block.
Ruth L Martin, Jeff S McDermott, Heinz J Salmen, Jason Palmatier, Bryan F Cox, Gary A Gintant. J Cardiovasc Pharmacol 2004
128
50



Strategies to reduce HERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilide.
João F S Carvalho, Julien Louvel, Maarten L J Doornbos, Elisabeth Klaasse, Zhiyi Yu, Johannes Brussee, Adriaan P IJzerman. J Med Chem 2013
18
50

Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
R H Schwinger, M Böhm, C Mittmann, K La Rosée, E Erdmann. J Mol Cell Cardiol 1991
38
50


Synthesis and biological activity of KCB-328 and its analogues: novel class III antiarrhythmic agents with little reverse frequency dependence.
D I Kim, H Y Kim, L S Kwon, S D Park, G H Jeon, K Y Jung, J K Min, W H Nam, K Lee, Y S Chung,[...]. Bioorg Med Chem Lett 1999
4
50

Chronic haloperidol increases voltage-gated Na+ currents in mouse cortical neurons.
Weiqiang Chen, Fangfang Zhu, Jingfang Guo, Jiangtao Sheng, Wenli Li, Xiangfeng Zhao, Gefei Wang, Kangsheng Li. Biochem Biophys Res Commun 2014
4
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.